Respair key facts
as of Oct 2026- Developer of airway products intended to support clinicians and patients in critical care environments.
- Respair is valued at approximately $9.2M as of Oct 2026, set at its seed round, Jun 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $2.5M across 1 recorded rounds; the latest was Seed Round ($2.2M) in May 2025.
- Notable investors include Innovation Works, PIC Investment Group, AlphaLab Health, Global Center for Medical Innovation, LifeX Ventures — 7 tracked in total.
- Respair has filed 1 Form D with the SEC, most recently Jun 2025 ($2.2M sold to 7 investors).
- Status: Privately Held (backing).
Valued at $9.2M at its seed round, Jun 2025. Nothing has traded since.
- ·Watch Respair: the Monday email on marks, rounds and moves
Respair funding rounds
1 roundsRespair valuation
Respair was valued at $9.2 million at its seed round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Respair raised?
Respair has raised $2.5 million across 1 recorded round since 2025. The largest was a $2.2 million seed round in May 2025.
Respair has filed 1 Form D with the SEC, most recently in Jun 2025 ($2.2 million sold to 7 investors).
Respair investors
7 investors are on record for Respair, including Innovation Works, PIC Investment Group, AlphaLab Health and Global Center for Medical Innovation. The seed round in May 2025 drew 7 investors.
About Respair
Developer of airway products intended to support clinicians and patients in critical care environments. The company's technology replaces the error-prone inflatable cuff used on current breathing tubes with soft, pliable baffles that act like a stopper and comprehensively seal the airway without adding pressure, enabling patients to breathe without any secondary complications.
- Sector
- Healthcare
- HQ
- Pittsburgh, PA, United States
- Founded
- 2020
- Employees
- 6
- Website
- respairmed.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.